Categories Analysis, Technology, U.S. Markets News
G20 truce does not guarantee long-term growth prospects for chipmakers
Semiconductor stocks had a roll earlier this week after President Donald Trump and Chinese counterpart Xi Jinping managed to come close to a common ground at the G20 summit in Japan. Both the leaders promised to resume the trade talks, though the tariffs were not lifted.
The US also temporarily removed the blacklisting on Chinese telecommunication equipment company Huawei. Semiconductor investors took these favorable outcomes a bit too positively and sent most semiconductor stocks soaring.
The iShares Semiconductor Index (NASDAQ: SOXX) gained 4.5% on Monday, led by Advanced Micro Devices (NASDAQ: AMD), NXP Semiconductors (NASDAQ: NXPI) and Qualcomm (NASDAQ: QCOM).
However, over the next few days, the stocks pared most of the gains as investors realized a temporary truce does not guarantee either an end to the trade war or a continued growth environment to chipmakers.
There is also a lot of uncertainty relating to the said lifting of the ban, as Reuters reported that the Commerce Department continues to treat Huawei as a blacklisted company. So can US chipmakers supply components to the Chinese firm? Can’t say for sure.
Separately, irrespective of what happens to the trade war, a slowing Chinese economy doesn’t bode well for semiconductor makers back home. China’s manufacturing segment is going through one of its slowest phases, and decreased demand would certainly hurt US chipmakers with Chinese exposure.
As we are so close to another earnings season, it would make sense waiting for the quarterly results to get a clearer picture of the industry’s trajectory. Intel (NASDAQ: INTC) will kick off the semiconductor earnings Thursday, July 25.
iShares Semiconductor Index has gained 26.5% so far this year, outperforming the S&P 500 index, which has gained 18.4% during the same period.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company